Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 15.22
-0.08 (-0.52%)
At close: Nov 28, 2025
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 5.16 billion as of November 28, 2025. Its market cap has decreased by -32.39% in one year.
Market Cap
5.16B
Enterprise Value
5.48B
Revenue
1.01B
Ranking
n/a
PE Ratio
234.01
Stock Price
15.22
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 5.16B, an increase of 3,290.86%. That is a compound annual growth rate of 54.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 5.16B | -37.42% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | 1.06B | 169.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.33B |
| Pro Medicus | 27.87B |
| Cochlear | 18.34B |
| Sonic Healthcare | 11.56B |
| Ramsay Health Care | 8.34B |
| Ansell | 5.30B |
| Mesoblast | 3.49B |
| Neuren Pharmaceuticals | 2.43B |